Lymphoma, Intermediate-Grade
Information
- Disease name
- Lymphoma, Intermediate-Grade
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00546793 | Completed | Phase 1/Phase 2 | Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL | January 2008 | March 2013 |
| NCT00317096 | Unknown status | Phase 3 | FCM Versus R-FCM Followed by R-Maintenance or Observation Only | November 1998 | June 2021 |
| NCT01263418 | Withdrawn | Phase 2 | Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas | June 2011 | January 2018 |